A novel phosphotyrosine mimetic 4′-carboxymethyloxy-3′-phosphonophenylalanine (cpp): exploitation in the design of nonpeptide inhibitors of pp60Src SH2 domain

Noriyuki Kawahata(Ariadne Diagnostics (United States)), Tomi K. Sawyer(Merck & Co., Inc., Rahway, NJ, USA (United States)), Wei Guan(Guangzhou Experimental Station), D. T. Johnson(Memorial Hermann), Shelia M. Violette(Biogen (United States)), Marcos Hatada(Ariadne Diagnostics (United States)), William C. Shakespeare(Ariadne Diagnostics (United States)), Charles J. Eyermann(Ariadne Diagnostics (United States)), Catherine Bartlett(Ariadne Diagnostics (United States)), David C. Dalgarno(New Jersey Urology), Jeremy A. Smith(Ariadne Diagnostics (United States)), Yihan Wang(Boston Medical Center), Xiaode Lu(Ariadne Diagnostics (United States)), George P. Luke(Ariadne Diagnostics (United States)), Raji Sundaramoorthi(Ariadne Diagnostics (United States)), Regine S. Bohacek(Ariadne Diagnostics (United States)), Taylor Merry(Ariadne Diagnostics (United States)), Michael G. Yang(University of Pittsburgh)
Bioorganic & Medicinal Chemistry Letters
September 1, 2001
Cited by 21


Related Papers